Table 2.
Characteristics of included studies
| Trials and year | Region | No. hips (D/ND) | No. of patients | Procedure | Male (%) | Follow-up | Thromboprophylaxis | Antibiotics | QAS |
|---|---|---|---|---|---|---|---|---|---|
| Beer, 1991 | Columbus, USA | 12/12 | 12 | Bilateral | NA | 3 months | Sodium warfarin | NA | 15 |
| Murphy, 1993 | London, UK | 20/20 | 40 | Unilateral | NA | 10 days | NA | NA | 14 |
| Ritter, 1994 | Mooresville, Indiana | 78/62 | 140 | Unilateral | NA | Discharge | Aspirin | NA | 13 |
| O’Brien, 1997 | Belfast, UK | 440/432 | 872 | Unilateral | 42.32 | Discharge | Dextran & mechanical | Cefamandole | 20 |
| Ovadia, 1997 | Tel-Aviv, Israel | 18/12 | 30 | Unilateral | 50 | Discharge | Heparin | NA | 16 |
| Crevoisier, 1998 | Lausanne, Switzerland | 33/33 | 66 | Unilateral | NA | Discharge | Heparin | Cefazolin | 15 |
| Kim, 1998 | Seoul, Korea | 48/48 | 48 | Bilateral | 79.2 | 15 months | NA | NA | 20 |
| Niskanen, 2000 | Lahti, Finland | 27/31 | 58 | Unilateral | 37.9 | 2 months | LMWH | No name | 14 |
| Ravikumar, 2001 | Kent, UK | 12/13 | 23 | Unilateral or Bilateral | 47.8 | 6 weeks | Mechanical | Cefuroxime | 16 |
| Widman, 2002 | Stockholm, Sweden | 10/12 | 22 | Unilateral | 40.9 | NA | Dalteparin | Cloxacillin | 12 |
| Hill, 2003a | Dunfermline, UK | NA | 577 | Unilaterl or bilateral | NA | 6 months | NA | NA | 14 |
| Gonzalez DV, 2004 | New York, USA | 53/51 | 102 | Unilaterl or bilateral | 52.9 | 3 months | Unfractionated Heparin, LMWH or Acetylsalicylic acid | No name | 19 |
| Johansson, 2005 | Linkoping, Sweden | 54/51 | 105 | Unilateral | 50.5 | 2 months | Dalteparin | NA | 18 |
| Walmsley, 2005 | Dunfermline, UK | 282/295 | 552 | Unilaterl or bilateral | 38.6 | 36 months | LMWH | Cefuroxime | 20 |
| Matsuda, 2006 | Tokyo, Japan | 20/20 | 40 | Unilateral | 22.5 | More than 3 months | Mechanical | No name | 20 |
| Dora, 2007 | Zürich, Switzerland | 50/50 | 100 | Unilateral | 45 | 12 months | LMWH | Cephalosporin | 20 |
| Strahovnik, 2010 | Celje, Slovenia | 46/42(24H) 51/42(48H) | 139 | Unilateral | 33.1 | 3 months | LMWH | Cefazolin | 20 |
| Cheung, 2010 | Shropshire, UK | 52/48 | 100 | Unilateral | NA | 12 months | Aspirin & mechanical | Cefuroxime | 18 |
| Kleinert, 2012 | Zurich, Switzerland | 40/40 | 80 | Unilateral | 47.5 | 3 months | LMWH | Cefuroxime | 21 |
| Roth, 2012 | Munich, Germany | 40/40 | 80 | Unilateral | 41.3 | Discharge | LMWH | NA | 17 |
D drainage, ND no drainage, H hour, LMWH low-molecular-weight heparin, QAS quality assessment score, NA not mentioned
a Abstract only